Question 1

What is the share price of SAROJA PHARMA INDUS IND L today?

Accepted Answer

SAROJA PHARMA INDUS IND L (SAROJA) is trading at ₹40.8. The price shown is the latest available from the exchange feed and updates through the trading session.

Question 2

What is SAROJA’s P/E ratio versus the sector?

Accepted Answer

SAROJA trades at a P/E of 9.9. Its industry median is shown alongside it in Key Stats, so you can see at a glance whether the stock is priced above or below the businesses it competes with. A lower P/E is not automatically cheaper — it can also reflect slower expected growth.

Question 3

What is SAROJA’s dividend yield?

Accepted Answer

SAROJA has a dividend yield of 0.00%, based on dividends declared over the last twelve months against the current price. The full dividend history is on the News & Filings tab.

Question 4

What is SAROJA’s 52-week high and low?

Accepted Answer

SAROJA has traded between ₹40.8 and ₹40.8 over the past year. The Trading Data block shows where the current price sits inside that band.

Question 5

What is the market capitalisation of SAROJA PHARMA INDUS IND L?

Accepted Answer

SAROJA PHARMA INDUS IND L has a market capitalisation of ₹17 crore.

Question 6

What is SAROJA’s return on equity?

Accepted Answer

SAROJA reports a return on equity of 10.1%. ROE measures profit generated per rupee of shareholder capital, and is most meaningful compared against others in —.

Question 7

Who are SAROJA’s competitors?

Accepted Answer

The Peers block on this page lists other — companies with their price, P/E and market capitalisation. The Valuation tab compares multiples against the industry median in more depth.

Question 8

What is SAROJA’s promoter holding?

Accepted Answer

Promoters hold 73.02% of SAROJA. The Ownership tab shows the full shareholding pattern — promoter, FII, DII and public — and how each has moved across recent quarters.

Question 9

Which indices include SAROJA?

Accepted Answer

Index membership is listed in the Context block on this page, along with the weight SAROJA carries in each. That weight is what determines how much passive money tracks the stock.

Question 10

Is SAROJA PHARMA INDUS IND L a good buy?

Accepted Answer

We do not publish buy or sell calls. What this page gives you instead is the evidence: our Value & Investment Index for where the price sits against its own history, the Fundamental Strength Index for the quality of the business, an investment checklist of criteria applied to every stock, and pros and cons generated from SAROJA’s own numbers. The judgement is yours.

Revenue	₹70 crore
Net profit	₹2 crore
Operating margin	5%
EPS	₹4

SAROJA

SAROJA

Fundamental Strength

Profitability

Growth

Segment Results

Working Capital & Efficiency

SAROJA financial summary